TECH OFFER

Human Blood-Derived Mesenchymal Stem Cell to Repair Cartilage Defect

TECHNOLOGY OVERVIEW

The present invention provides a method of isolating, culturing, proliferating and maintenance of the mesenchymal stem cells (MSCS) derived from human peripheral blood. The peripheral blood is a (clinically accessible) potential source of MSCS. The method used in the present invention is reliable, involved minimal invasive procedures, in less time, and is cost-consuming. MSCS is able to isolate, purify, greatly multiply and differentiate into cartilage cells for the use of treating cartilage defects. Thus, the present invention also provides a potential cell therapy to repair cartilage defects from the human blood-derived chondrogenic-MSCS.

Mega - Trends

Healthcare

Technology Readiness Level (TRL)

TRL 5

Patent Number

MY-157059-A

Get the technology fact sheet here:

Contact person for this offer:

ChM Dr. Lee Ching Shya, PhD (Dual), RTTP

Technology Transfer Manager

Email: leecs@um.edu.my

Tel: +603-7967-7351/ 013-2250151

press to zoom

press to zoom
1/1

MORE INFORMATION

You have a question to know about technologies or cooperations? 
Please Contact Us:

+603 - 7967 7351 / 013-2250151